ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• ICH E6(R3) Is Here: What Your Centralized Monitoring Strategy Needs

  ICH E6(R3) turns best practices into regulatory mandates. Learn how to maintain sponsor accountability and implement proportionate centralized monitoring through a unified, auditable data layer.

• Enhancing Activity And Gait Monitoring In Children Using DHTs

  Discover how advancements in digital health technology are reshaping pediatric research and enhancing our understanding of physical activity and gait in children.

• Patient-Centric Clinical Trials: The Power Of Choice

  Patient-centric trials, advocated by the FDA, focus on offering choices to improve engagement, diversity, and data quality. Explore how expanding patient choice can benefit clinical trials.

• EDC Selected To Support Biotech Advances In Diabetes

  Find out why one leading biotechnology company keeps choosing this eClinical technologies and services provider for EDC assistance.

• Realizing The Potential Of AI And Machine Learning In Clinical Research

  The life sciences industry has not yet scaled or realized the full potential of AI/ML. Here are four real-world use cases that can encourage researchers to unlock new efficiencies and insights in their studies.

• Elevating Rater Training For More Reliable Study Outcomes

  Well-trained raters are key to generating high-quality, consistent clinical trial data. Explore a program offering customized training tailored to the experience levels of raters.

• FDA Pushes For Patient Voice: ePRO In Oncology Trials

  FDA urges sponsors and CROs to include patient voices in oncology trials. Discover why it matters and how to start integrating this approach.

• How eConsent Improves The Trial Experience For Patients And Sites

  In part one of this series, the author dives into how electronic consent platforms are simplifying and improving the trial experience for patients and sites.

• Achieving Clinical Operations Excellence

  Learn how Revvity Signals Software clinical solutions give clinical operations organizations the unprecedented ability to reduce the time, cost and risk of running clinical trials while accelerating the time to market for products across the entire portfolio of clinical candidates.

• Immuno-Inflammation Clinical Trials: Challenges And Solutions

  Learn why having a strong and robust eCOA solution, along with an understanding of the specific challenges of this therapeutic area, is critical to the success of immuno-inflammation clinical trials.